Based on the results, HemoHIM is potential candidate for the treatment of gastritis and gastric ulcers.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: